Eli Lilly & Co. agreed to buy Verve Therapeutics Inc., a US biotech that’s seeking to use gene editing to prevent clogged arteries, for as much as $1.3 billion.

Eli Lilly to Acquire Gene-Editing Therapy Developer Verve Therapeutics for up to $1.3 Billion, Companies Say (Reuters) -Eli Lilly will acquire Verve Therapeutics for up to $1.3 billion, the ...

By MATTHEW PERRONE, Associated Press WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for ...

The late, great Gene Hackman was one of the finest actors to ever grace a cinema screen. When he died in February 2025, the outpouring of love and affection for him and his work was overwhelming. He ...

Menez has been on a roll since November. He crushed the late Pick 4 on Breeders' Cup Saturday for a $5,303 windfall. He nailed the winner, trifecta and superfecta in the Florida Derby for a $529.60 ...

With an estimated four million Nigerians affected by sickle cell disease, experts have called on the federal government to invest in the local production of gene therapy treatments. The appeal was ...

Using a tool called Automated Meiotic Mapping (AMM) that was developed at UT Southwestern Medical Center, a team of researchers has identified a gene that appears to be key to regulating food intake.

FDA reassures rare disease advocates that ‘being flexible’ is plan for gene therapy At roundtable, Kennedy, Prasad, and others express openness to quick approvals Adobe By Jason Mast June 6, 2025 ...

CALDWELL, Texas (KBTX) -Law enforcement officers, community leaders, and family gathered Thursday afternoon to honor the life and legacy of Burleson County Sheriff Gene Hermes. Visitation was held ...

Prasad, who in the past has criticized the FDA’s accelerated approval of a gene therapy for Duchenne muscular dystrophy, showed support for flexible trial designs and endpoints when appropriate for ...

Nine-month-old KJ Muldoon is the first patient to successfully receive personalized CRISPR gene editing therapy. After 300 days in the hospital, baby KJ has returned home.

Now, he’s finally home after becoming the first patient ever treated with personalized gene-editing therapy. His family sits down exclusively with NBC’s Laura Jarrett to talk about his ...